Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3222132
Max Phase: Preclinical
Molecular Formula: C35H46BrCl2N5O9S2
Molecular Weight: 895.72
Molecule Type: Small molecule
Associated Items:
ID: ALA3222132
Max Phase: Preclinical
Molecular Formula: C35H46BrCl2N5O9S2
Molecular Weight: 895.72
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CNC(=O)c1cc2c(cc1C(=O)NC[C@H](NS(=O)(=O)c1c(Cl)sc(Cl)c1Br)C(=O)OC(C)(C)C)CN(C(=O)CCC1CCN(C(=O)OC(C)(C)C)CC1)C2
Standard InChI: InChI=1S/C35H46BrCl2N5O9S2/c1-34(2,3)51-32(47)24(41-54(49,50)27-26(36)28(37)53-29(27)38)16-40-31(46)23-15-21-18-43(17-20(21)14-22(23)30(45)39-7)25(44)9-8-19-10-12-42(13-11-19)33(48)52-35(4,5)6/h14-15,19,24,41H,8-13,16-18H2,1-7H3,(H,39,45)(H,40,46)/t24-/m0/s1
Standard InChI Key: CYSWDCPZOPRRBM-DEOSSOPVSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 895.72 | Molecular Weight (Monoisotopic): 893.1297 | AlogP: 5.87 | #Rotatable Bonds: 11 |
Polar Surface Area: 180.52 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 6.84 | CX Basic pKa: | CX LogP: 4.67 | CX LogD: 4.16 |
Aromatic Rings: 2 | Heavy Atoms: 54 | QED Weighted: 0.23 | Np Likeness Score: -0.90 |
1. Yap JL, Chauhan J, Jung K, Chen L, Prochownik EV, Fletcher S. (2012) Small-molecule inhibitors of dimeric transcription factors: Antagonism of proteinprotein and proteinDNA interactions, 3 (5): [10.1039/C2MD00289B] |
Source(1):